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Abstract
Oncostatin M (OSM) is a member of the interleukin-6 cytokine family and regulates eg. gene activation, cell
survival, proliferation and differentiation. OSM binds to a receptor complex consisting of the ubiquitously expressed
signal transducer gp130 and the ligand binding OSM receptor subunit, which is expressed on a specific subset of
primary afferent neurons. In the present study, the effect of OSM on heat nociception was investigated in
nociceptor-specific gp130 knock-out (SNS-gp130
-/-) and gp130 floxed (gp130
fl/fl) mice.
Subcutaneous injection of pathophysiologically relevant concentrations of OSM into the hind-paw of C57BL6J wild
type mice significantly reduced paw withdrawal latencies to heat stimulation. In contrast to gp130
fl/fl mice, OSM did
not induce heat hypersensitivity in vivo in SNS-gp130
-/- mice. OSM applied at the receptive fields of sensory
neurons in in vitro skin-nerve preparations showed that OSM significantly increased the discharge rate during a
standard ramp-shaped heat stimulus. The capsaicin- and heat-sensitive ion channel TRPV1, expressed on a
subpopulation of nociceptive neurons, has been shown to play an important role in inflammation-induced heat
hypersensitivity. Stimulation of cultured dorsal root ganglion neurons with OSM resulted in potentiation of
capsaicin induced ionic currents. In line with these recordings, mice with a null mutation of the TRPV1 gene did
not show any signs of OSM-induced heat hypersensitivity in vivo.
The present data suggest that OSM induces thermal hypersensitivity by directly sensitizing nociceptors via OSMR-
gp130 receptor mediated potentiation of TRPV1.
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Background
Oncostatin M (OSM) is a monomeric glycoprotein that
belongs to the interleukin-6 (IL-6) family of proinflamma-
tory cytokines. Besides OSM, this family consists of IL-6,
interleukin-11 (IL-11), leukemia inhibitory factor (LIF),
ciliary neurotrophic factor (CNTF) and cardiotrophin-1
[1]. OSM is produced by several cell types of the immune
system, including activated monocytes and T-cells [2],
macrophages [3], eosinophils and polymorphonuclear neu-
trophils [4,5]. The physiological functions of OSM are
divers, ranging from cell type specific proliferative or anti-
proliferative effects and maturation of fetal hepatocytes to
regulation of the inflammatory response.
In general, IL-6 related cytokines bind to their specific
receptor and requires dimerization with the common sig-
nal transducer gp130 to form a functional receptor com-
plex [6]. Whereas IL-6 binds to its receptor IL-6R and
dimerizes with two molecules of gp130, OSM receptor
(OSMR) signaling requires just a single gp130 molecule to
exert its effects. Human OSM is capable of binding not
only to the OSMR but also to the LIF receptor, in contrast
to murine OSM that only binds to the OSMR [7]. A subset
of murine afferent sensory nerve fibers expresses OSMR.
These OSMR-positive neurons also express the heat
receptor TRPV1 and the purinergic receptors that are well
recognized mediators in pain perception [8]. Studies in
OSM knock-out mice showed that OSM has a profound
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tors. The absence of OSM leads to a substantial decrease
in the number of OSMR-positive neurons [9]. Moreover,
OSM-deficient mice displayed reduced nociceptive beha-
vior to acute noxious mechanical, thermal and chemical
stimuli.
During inflammation, release of inflammatory media-
tors and pro-inflammatory cytokines occurs and in ele-
vated levels of OSM are found in patients with
rheumatoid arthritis up to 1 ng/ml in synovial fluid
[10,11]. In addition, acute inflammation of the skin by
complete Freund’s adjuvant results in elevated levels of
OSM, but expression of OSMR in dorsal root ganglia
remains unaltered [12]. Inflammatory mediators cause
hypersensitivity to noxious heat and mechanical stimuli
of the inflamed tissue. Members of the IL-6 cytokine
family are involved in chronic pain during chronic
inflammation like rheumatoid arthritis and this is at
least partially due to the sensitization of primary noci-
ceptive afferents innervating the inflamed tissue. IL-6/
gp130 receptor-mediated signaling in Nav1.8 expressing
nociceptive afferents induces increased heat sensitivity
both in vitro and in vivo through direct regulation of
TRPV1. In vitro, gp130-deficient nociceptors are unre-
sponsive to IL-6 stimulation with regard to sensitization
of TRPV1. Furthermore, mice lacking gp130 in nocicep-
tors display reduced levels of pain perception induced
by inflammation and tumor growth [13].
Since ligand binding induces OSMR heteromerization
with gp130 and OSMR-positive neurons coexpress
TRPV1 in mice, we set out to determine the effect of
OSM on heat nociception in nociceptor-specific gp130
knock-out (SNS-gp130
-/-)a n dg p 1 3 0f l o x e d( gp130
fl/fl)
mouse strains. Our results demonstrate that OSM
induces heat hypersensitivity by directly sensitizing heat
nociceptive neurons via receptor-mediated potentiation
of ionic currents that are induced by the TRPV1 stimu-
lant capsaicin. Furthermore,w ef i n dt h a tt h es u b s e to f
OSM-sensitive nociceptors seems to contribute signifi-
cantly to heat hypersensitivity.
Results
To investigate whether OSM can induce heat hypersen-
sitivity dependent on OSMR-gp130 receptor activation,
in this study we used sensory neuron specific (SNS)
knock out of the signal transducer gp130. Small and
medium sized nociceptive sensory neurons exclusively
express the sodium channel Nav1.8 and its promotor
has been used to specifically express the Cre-recombi-
nase in sensory neurons (SNS-Cre). Mice homozygous
for the floxed allele of the mouse gp130 gene (gp130
fl/fl)
were crossed with SNS-Cre mice to create SNS-gp130
-/-
[13].
Oncostatin M Receptor b and signal transducer gp130 are
co-expressed in DRG neurons and potentiate capsaicin-
activated currents
For OSM to exert its’ action on DRG neurons, both the
OSMR and gp130 should be expressed in the same neu-
ron. Live-cell labeling of gp130
fl/fl neurons against the
OSMR and gp130 revealed that all OSMR-positive cells
(n = 27) express gp130 (Figure 1A, upper panel). To eluci-
date whether OSM directly affects heat sensitivity of sen-
sory neurons, mice with a conditional deletion of gp130
(SNS-gp130
-/-) and control gp130
fl/fl [13] were used. In
neurons isolated from SNS-gp130
-/- mice, OSMR-positive
neurons lacked detectable levels of full length gp130 at the
plasmamembrane as observed by live-cell labeling (n = 41,
Figure 1A, middle panel). Furthermore, we found that all
OSMR-positive in both gp130
fl/fl (Figure 1A, lower panel)
and SNS-gp130
-/- (data not shown) neurons also express
TRPV1 and is in accordance to previous findings [8]
The nociceptor-specific heat- and capsaicin-sensitive ion
channel TRPV1 is essential for the induction of inflamma-
tory pain and hyperalgesia [14,15]. There is an expanding
amount of evidence that inflammatory mediators are cap-
able of regulating TRPV1 activity and this process is essen-
tial in the generation of heat hypersensitivity. In a cellular
model of nociception, modulation of TRPV1 can be
addressed by recording capsaicin-induced currents (Icaps)
in small diameter neurons. To examine whether OSM
causes acute and direct modulation of heat-sensitive neu-
rons, we challenged the neurons with 5 ng/ml OSM (simi-
lar to previous studies [16-18] and comparable to OSM
levels found in chronic RA patients [11]). Patch-clamp
experiments were carried out on isolated DRG neurons of
adult gp130
fl/fl and SNS-gp130
-/- mice and were immuno-
labeled against both OSMR and gp130. In all OSMR-posi-
tive cells that were recorded, repetitive application of cap-
saicin evoked reproducible inward currents of relatively
constant amplitude. Challenging the gp130
fl/fl DRG neu-
rons with OSM resulted in a marked potentiation of sub-
sequent Icaps stimulations in all neurons investigated
(Figure 1B, top trace); maximum amplitudes of Icaps
increased by a factor of 2.49 ± 0.31 (Figure 1C, black bars).
When OSMR-negative/gp130-positive neurons were
recorded and stimulated with OSM, no potentiation of
Icaps was observed (n = 3, data not shown). In OSMR-posi-
tive/gp130-negative neurons obtained from SNS-gp130
-/-,
OSM induced augmentation of Icaps was absent (Figure
1B, lower trace, Figure 1C, red bars).
The signal transducer gp130 mediates Oncostatin
M-induced nociceptor sensitization in vitro
In order to address the question whether OSM can also
sensitize nociceptive primary afferents within innervated
tissue, we performed single fiber recordings from
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Figure 1 OSM requires the expression of gp130 in nociceptive neurons to potentiate capsaicin-evoked currents. (A) Expression of OSMR,
gp130 and TRPV1 in gp130
fl/fl and SNS-gp130
-/- cultured DRG neurons. OSMR and gp130 immunoreactivity was observed in gp130
fl/fl DRG
neurons (upper panel). In addition, the OSMR-positive neurons of gp130
fl/fl mice also displayed TRPV1 immunoreactivity (middle panel). The SNS-
gp130
-/- DRG neurons were devoid of gp130 (lower panel) while maintaining OSMR expression. Scale bar 10 μM. (B) In electrophysiological
recordings of gp130
fl/fl neurons OSM (5 ng/ml) induces a transient potentiation of capsaicin-responsive currents (upper trace), whereas in DRG
neurons lacking the gp130 expression OSM did not increase the capsaicin-induced currents (lower trace). Quantification of normalized ionic
currents (Icaps/IcapsIII) reveals that OSM increases capsaicin currents approximately 2.5 fold within 2 minutes in OSMR-positive gp130 nociceptors
compared to the normalized currents recorded in OSMR-positive/gp130-negative SNS-gp130
-/- nociceptive neurons. ** p < 0.01, *** p < 0.001,
Mann-Whitney U-test, white numbers inside the individual bars indicate the number of recorded Icaps.
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Page 3 of 10unmyelinated, heat-sensitive primary afferents in a skin
nerve in vitro preparation [19,20]. Polymodal nocicep-
tors from gp130
fl/fl responded to a standard ramp-
shaped heat stimulus with an average discharge rate of
2.19 ± 0.44 imp/s (n = 8) (Figure 2A, left panel, open
bars). At the end of the heat stimulus, the heat-sensitive
fibers from gp130
fl/fl responded with a total of 33.9 ±
7.0 action potentials (Figure 2A, right panel, open
squares). The nociceptive fibers started to respond at
41.3 ± 0.9°C (Figure 2C, left graph, black open bar) and
the maximal amount of action potentials generated by
the gp130
fl/fl fibers was recorded at an average tempera-
ture of 44.1 ± 0.74°C (Figure 2C, right graph, black
open bar). Exposing the receptive fields from gp130
fl/fl
preparations to a conditioning OSM (5 ng/ml) stimulus,
the average discharge rate increased to 3.86 ± 0.76 imp/s
during the consecutive heat stimulus (Figure 2B, left
panel, black bars) and the total number of discharges is
significantly increased to 62.1 ± 11.8 (Figure 2A, right
panel, closed squares). In addition, the threshold tem-
perature to which fibers started generating action poten-
tials is significantly decreased (Figure 2C, left graph,
39.79 ± 0.6°C, p < 0.05). Besides, the average temperature
at which the highest discharge rate was recorded shifted
non-significantly to slightly lower temperatures (42.6 ±
0.6°C, Figure 2C, right graph).
In preparations from SNS-gp130
-/- mice, the heat-sensi-
tive fibers reacted with the highest discharge frequency at
an average temperature of 42.6 ± 1.0°C (Figure 2C, right
graph) and during the heat stimulus a total of 28.6 ± 7.3
action potentials were recorded (Figure 2B, right graph,
open circles) with an average discharge rate of 1.43 ±
0.25 imp/s (Figure 2B, left graph, open bars). In contrast
to the gp130
fl/fl preparations, OSM did not enhance heat
responses in SNS-gp130
-/- preparations (Figure 2B, right
graph, closed circles; total discharges per fiber: 25.9 ± 6.0,
Figure 2B, left graph, red bars; average discharge rate:
1.29 ± 0.25 imp/s). Neither was the threshold tempera-
ture altered by OSM (Figure 2C, left graph before; 40.9 ±
0.5°C, after; 41.0 ± 0.5°C) nor was the average tempera-
ture at which the highest discharge rates were recorded
(44.0 ± 0.78 imp/s, Figure 2C, right graph).
Oncostatin M induces hypersensitivity to heat stimuli
in vivo
To investigate the relevance of the present findings in vivo,
heat sensitivity was assessed in mice using the Hargreaves
test before and after subcutaneous injection of OSM.
Injection of 10 ng/10 μl OSM reduced paw withdrawal
latencies (PWL) in C57BL6J wild type (wt)m i c ea tt h e
ipsilateral side from 9.95 ± 0.79s to 5.73 ± 0.90s at the first
measurement 30 minutes after injection compared to the
contralateral side. This hypersensitivity to heat remained
significant for 24 hours after injection (Figure 3A). To
address the importance of gp130 for OSM-induced heat
hypersensitivity in vivo, SNS-gp130
-/- and gp130
fl/fl were
used in behavioral tests. OSM-induced heat hypersensitiv-
ity was observed after 30 min. in gp130
fl/fl (Figure 3B,
PWL 9.93 ± 0.87s before vs. 4.44 ± 0.72s after OSM) and
remained substantially different for 4 hours compared to
the contralateral side (data not shown). Similar to wt mice,
the PWL of gp130
fl/fl mice remained significantly different
up to 24 hours after injection of OSM in the hindpaw.
Injection of the vehicle alone in the hindpaw did not cause
any changes in heat sensation [21]. In SNS-gp130
-/- mice,
there was no significant decrease of the paw withdrawal
latency (Figure 3B, from 9.80 ± 0.63s to 7.17 ± 0.82s)
observed after subcutaneous injection of OSM (10 ng/10
μl) compared to the uninjected contralateral site (9.66 ±
0.78s to 7.41 ± 0.76s, data not shown). The OSM-induced
decrease of PWL in gp130
fl/fl was already significantly
reduced 30 minutes after injection compared to the PWL
of SNS-gp130
-/- mice (Figure 3B). Behavioral studies per-
formed on motor pathways in both gp130
fl/fl (n = 8) and
SNS-gp130
-/- (n = 8) mice using the rotarod test did not
show any differences between the 2 mouse strains (data
not shown). These results strongly suggest that the signal
transducer gp130 in nociceptors is essential in mediating
OSM induced heat hypersensitivity in mice.
During inflammatory conditions, the increased heat
hypersensitivity is dependent on TRPV1, and TRPV1-defi-
cient mice do not develop heat hypersensitivity [22]. Since
OSM can be secreted during inflammation by T lympho-
cytes [2] and neutrophils [4], we examined whether OSM
would induce heat hypersensitivity in mice with a global
deletion of TRPV1 (TRPV1
-/-). Intracutaneous injection of
OSM into the plantar hindpaw of TRPV1
-/- mice did not
result in a notable change in heat sensitivity compared to
baseline values or to the contralateral side (Figure 3C).
Furthermore, there was no significant difference observed
between the PWLs of wt and TRPV1
-/- mice at the con-
tralateral side (data not shown).
Discussion
Our data show OSM induced thermal hypersensitivity via
direct regulation of nociceptor sensitivity to heat stimuli.
Furthermore, the gp130 signal tranducer, which hetero-
merizes with the OSMR to form a functional receptor
complex, is of critical importance in mediating the OSM-
induced heat hypersensitivity in mice. This is justified by
the observation that nociceptors from SNS-gp130
-/- mice
are largely protected from OSM-induced heat sensitization
and by the absence of OSM induced potentiation of Icaps in
gp130-deficient sensory neurons. Furthermore, we show
that the TRPV1 ion channel is the convergence point for
thermal hypersensitivity mediated by Oncostatin M.
Proinflammatory cytokines including OSM that depend
on gp130 for signal transduction require the presence of
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Figure 2 Discharge characteristics of heat-sensitive C-fibers innervating the dorsal site of the hindpaw recorded in an in vitro skin-
nerve preparation from gp130
fl/fl and SNS-gp130
-/- mice upon a heat-ramp stimulus. (A) Left panel; the discharge pattern of gp130
fl/fl C-
fibers is changed upon stimulation with 5 ng/ml OSM, the amount of discharges recorded is increased and has shifted to lower temperatures.
The mean cumulative discharge rates in heat-sensitive C-fibers from gp130
fl/fl were significantly higher after perfusion with 5 ng/ml OSM (filled
squares, n = 8) compared with rate of discharge before OSM application (open squares, n = 8). (B) However, in SNS-gp130
-/- C-fibers, the
discharge pattern evoked by a heat ramp stimulus is unaltered after stimulation with OSM (left panel). Furthermore, OSM perfusion failed to
increase the mean cumulative discharge rate of heat-sensitive fibers in SNS-gp130
-/- skin-nerve preparations (control; open circles, +OSM; filled
circles, n = 8). (C) The discharge threshold temperature of gp130
fl/fl (n = 8,) is significantly decreased after stimulation with OSM (5 ng/ml),
whereas in SNS-gp130
-/- the threshold temperature remained unchanged (left bar graph, n = 8). The temperature at which the maximal
discharge rate was achieved was unaltered in both gp130
fl/fl and SNS-gp130
-/- (right bar graph, n = 8). * p < 0.05, Wilcoxon signed rank test.
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Figure 3 OSM induces thermal hypersensitivity depending on gp130 and TRPV1. (A) Changes in heat sensitivity following hindpaw
injection of OSM in C57BL6J wildtype mice. Paw withdrawal latencies were determined at the injected (black squares) and the uninjected
hindpaw (black open circles) in response to ramp-shaped heat stimuli and were significantly attenuated at all time points at the ipsilateral site
compared to contralateral site (n = 10). (B) Comparison of the PWL between both gp130
fl/fl and SNS-gp130
-/- mice at the OSM injected hindpaw
shows a significant difference; the PWL of gp130
fl/fl (black squares, n = 10) are significantly shorter than those of SNS-gp130
-/- (red squares, n =
13) starting after 30 minutes until 4 hours after OSM injection. (C) In contrast, the PWL in response to ramp-shaped heat stimuli applied to the
plantar side of the hindpaw ipsilateral (red open circle) and contralateral (red squares) of TRPV1
-/- mice (n = 11) did not significantly change after
OSM injection. * p < 0.05, ** p < 0.01, *** p < 0.001, 2-way repeated ANOVA.
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Page 6 of 10specific ligand binding, soluble or membrane bound,
receptor subunits as well as the presence of gp130 signal
transducer to transduce the signal into the cytosol [23,24].
The majority of nociceptive neurons in mice express
gp130 and can be activated by classical transsignaling
routes via soluble receptors, e g. for IL-6 [25]. Therefore,
activation of specific DRG neuron subpopulations can
only be discriminated by different expression patterns for
specific membrane bound receptors. Approximately 13%
of the DRG neurons of C57BL6 wild type mice express the
O S M Ra n di ti sm o s tp r e v a l e n ti ns m a l l - s i z e dn e u r o n s
[26]. Furthermore, all OSMR-positive neurons express the
signal transducer gp130 and classical nociceptive markers
TRPV1 and P2X3 receptors. Typically, the OSMR expres-
sing neurons are non-peptidergic, but are rather character-
ized by expression of TrkA (63%), Ret (28%) and/or IB4
(58%). Our observation that all OSMR positive cells
derived from C57BL6J or gp130
fl/fl DRG neurons are co-
expressing gp130 is in agreement with these previous find-
ings [26]. As expected, all OSMR-positive neurons were
responsive to capsaicin in our electrophysiogical record-
ings and responded to OSM with a potentiation of Icaps.
Oncostatin M has an important role in the development
of nociceptive neurons. The OSMR expression is induced
after p0 in the DRGs and reaches maximal expression
after p14. The kinetics of OSMR expression is not altered
in OSM
-/- mice, however the total number of OSMR-posi-
tive cells is dramatically reduced. Moreover, the number
of TRPV1 and/or P2X3 positive neurons is even further
decreased, resulting in decreased nociceptive behavior
upon various nociceptive models [9]. Our data obtained
from SNS-gp130
-/- mice in behavioral studies and skin-
nerve preparations similarly show decreased OSM-
induced nociceptive behavior to heat. The PWL in
Hargreaves tests are not reduced after OSM injection
neither is the discharge rate in skin-nerve preparations
after OSM-perfusion. Undoubtedly, according to our
results, OSM and the OSM receptor are important media-
tors of thermal hypersensitivity of preexisting polymodal
nociceptors in adult mice.
Furthermore, our behavioral studies show that both
gp130 and TRPV1 are required for developing OSM-
induced heat hypersensitivity. Previously, our lab pre-
sented data that IL-6 increases heat sensitivity of nocicep-
tors through modulation of TRPV1 and is completely
dependent on gp130. Both OSM and IL-6 require gp130
for signal transduction, OSMR dimerizes with a single
gp130 molecule whereas the IL-6R associates with two
gp130 molecules [27,28]. Although, the intracellular signal
transduction pathways are quite similar, both will activate
Shp2-Gab1 and the JAK/STAT signaling pathway, with
the only difference that OSMR can activate STAT1, -3,
and -5, whereas IL-6 only activates STAT1 and -3 [29,30].
However, the heat hypersensitivity induced by IL-6 relies
on TRPV1 modulation via Gab1, PI3K and PKCδ [13].
Since, the time course of OSM-induced potentiation of
capsaicin currents is very similar to the IL-6 mediated
potentiation of TRPV1 currents in gp130
fl/fl and wildtype
DRGs we therefore assume that OSMR/gp130 uses the
same pathway for heat sensitization as we have previously
published for IL-6/gp130.
OSM and the OSMR are well-known players during
various inflammatory conditions. For example, OSM is a
potent cytokine that induces cutaneous inflammation
after intradermal injection in mice, and results in neutro-
phil infiltration [31]. Besides, skin and breast tissue
inflammation is associated with psoriasin (S100A7)
expression, which is potently increased by OSM in
human breast cancer cells in vitro [32]. Moreover, many
(auto-) inflammatory diseases are related to OSM, like
rheumatoid arthritis [10], atherosclerosis [33], psoriasis
and atopic dermatitis [2]. Oncostatin M has a pivotal role
in rheumatoid arthritis (RA), where increased levels of
OSM are found in the synovial fluid of RA patients.
Synovial fibroblasts are stimulated to proliferate and to
produce IL-6 by OSM [34]. These findings combined
with the fact that RA coincides with increased mechani-
cal and thermal sensitivity [35,36], we assume that inhi-
biting OSM signaling by a novel strategy with soluble
gp130 [6,37] or by a soluble OSMR-gp130 fusion protein
[38] would effectively reduce OSM-induced hypersensi-
tivity in RA.
Although expression of OSM and OSMR has been
reported previously and a role for OSM has been shown
for nociceptor development, our data for the first time
demonstrate the function of OSM in inducing thermal
hypersensitivity in mice. Our data show that OSM potenti-
ates Icaps and sensitizes nociceptors via regulation of
TRPV1. Although we cannot rule out the OSM mediated
indirect influence of immune cells, like neutrophils and
macrophages, or keratinocytes in in vivo experiments, we
have provided genetic evidence that OSM acts directly on
capsaicin-responsive nociceptive neurons via the common
gp130 signal transducer expressed in sensory neurons.
Materials and methods
Genetically modified mice
SNS-gp130
-/- and gp130
fl/fl mice were generated, bred
and genotyped as described previously [13]. All mice
were maintained under SPF (specific pathogen free) con-
ditions. Littermates were used in all experiments to con-
trol for background effects and all animal use
procedures were in accordance with ethical guidelines
and animal welfare standards according to Austrian law.
All behavioral measurements were done in awake,
unrestrained, age-matched male mice that were > 8
weeks old by individuals who were blinded to the geno-
type of the mice being analyzed.
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All lumbar (L1-L6) dorsal root ganglia (DRG) containing
the cell bodies of primary afferents that project into the
hindpaw were harvested from adult mice as previously
published [13,39]. After removal of the connective tissue,
ganglia were incubated in Liberase Blendzyme 1 (9 mg/
100 ml DMEM, Roche) for 2 times 30 min. After washing
with PBS (PAA), 1x Trypsin-EDTA (Invitrogen) was
a d d e df o r1 5m i n .a n dD R Gw e r ew a s h e dw i t hT N B ™
medium (Biochrom) supplemented with L-glutamin (Invi-
trogen), penicillin G sodium, streptomycin sulfate (Invitro-
gen), and Protein-Lipid-Komplex™ (Biochrom). The DRG
were dissociated with a fire-polished Pasteur pipette and
centrifuged through a 3.5% BSA gradient (Sigma) to elimi-
nate non-neuronal cells. The sensory neurons were resus-
pended, plated on coverslips coated with poly-L-Lysine/
laminin-1 (Sigma), and cultivated in supplemented TNB™
containing mNGF 2.5S (Alomone Labs, 10 μg/100 ml
TNB-medium) at 37°C in 5% CO2 for 24-36 h.
Immunocytochemistry and live-cell labeling
DRG neurons were dissociated according to the protocol
and plated on coverslips. After 24 h in culture, neurons
were fixed with 4% PFA for 20 min, permeabilized with
0.01% TX-100 (Sigma) for 2 min and blocked with block-
ing buffer (BB, 10% goat serum in PBS) for 30 min. Cells
were incubated with primary antibodies against OSMR
(MLB) and TRPV1 (Millipore) in BB (1:50 and 1:1000
respectively) for 1 h at room temperature (RT), washed
with PBS, and incubated with secondary antibodies
(1:1000) for 30 min at RT.
Overnight DRG neuron cultures were live cell labeled
for gp130 and/or OSMR expression shortly before record-
ing. Cultures were incubated on RT with primary antibo-
dies OSMR and gp130 (Neuromics) diluted in TNB™
medium (1:25 and 1:50 respectively) for 45 min, washed
with TNB™ medium for 10 min, and incubated with
appropriate secondary antibodies (AlexaFluor-488 and
-594 conjugated, Invitrogen) diluted in TNB™ medium
(1:500) for 30 min. Subsequently cells were washed twice
with TNB™ medium.
The TRPV1 antibody used does not stain murine
TRPV1
-/- DRG neurons as shown previously [13]. Further-
more, SNS-gp130
-/- DRG neurons do not display gp130
staining at the plasmamembrane when live labeled, while
gp130
fl/fl neurons do [13]. The OSM antibody used only
stained approximately 13% of non-permeabilized cultured
neurons with a clear plasmamembrane staining whereas
the remainder of the neurons did not. Besides, when
OSM-negative/gp130-positive neurons were recorded and
stimulated with OSM, no potentiation of Icaps was
observed (n = 3), providing specificity of the OSM
antibody.
Patch-clamp recordings
DRG neurons in culture were used for electrophysiology
18 to 28 h after plating. Ionic currents were recorded from
isolated neurons in the whole-cell voltage-clamp config-
uration of the patch-clamp technique as previously pub-
lished [13,21,39]. ECS contained (in mM): 150 NaCl,
5 KCl, 0.1 CaCl2,1M g C l 2 ( a l lS i g m a ) ,1 0g l u c o s e ,a n d
10 HEPES (Merck), at pH 7.3 adjusted with NaOH
(Merck). Calcium was reduced to 0.1 mM to avoid desen-
sitization of capsaicin-induced currents. Borosilicate glass
pipettes (Science Products) pulled with a horizontal puller
(Sutter Instruments Company) were filled with internal
solution (ICS) (in mM): 148 KCl, 2 MgCl2,2N a - A T P ,
0.1 CaCl2, 1 EGTA (all Sigma), and 10 HEPES (Merck), at
pH 7.3 adjusted with KOH (Merck). After filling, electrode
resistance was 4-5 MΩ. Neurons were clamped at -80 mV
holding potential. Currents were sampled at 3 kHz and fil-
tered at 2.9 kHz, and recorded with an EPC 9 (HEKA) and
the Pulse v8.74 software (HEKA). A seven barrel system
with common outlet was used for fast drug administration
(WAS 02, Dittel, Prague). Capsaicin-activated inward cur-
rents (Icaps) were elicited by applying 0.5 μM capsaicin
(Sigma) for 10 s followed by a 2 min washout with control
solution. Capsaicin stimulation was repeated 3 times
before OSM (5 ng/ml in ECS, R&D systems) was applied
for 1 min immediately before capsaicin for conditioning
stimulation. Experiments were performed at room tem-
perature and only one neuron was tested per Petri dish.
Skin-nerve preparation and single fiber recordings
An in vitro skin-nerve preparation was used to investigate
the properties of the afferent nerve fibers innervating the
skin of the mouse dorsal hindpaw as previously published
[19,20]. Briefly, the preparation was superfused (15 ml/
min) with an oxygen-saturated modified synthetic intersti-
tial fluid solution containing (in mM) 108 NaCl, 3.48 KCl,
3.5 MgSO4, 26 NaHCO3, 1.7 NaH2PO4,2 . 0C a C l 2,9 . 6
sodium gluconate, 5.5 glucose, 7.6 sucrose at temperature
of 31 ± 1°C, and pH7.4 ± 0.05. Action potentials of single
sensory neurons were recorded extracellularly from fine
filaments dissected from the saphenous nerve, amplified
(5000-fold), filtered (low pass 1 KHz, high pass 100 Hz),
visualized on oscilloscope, and stored on a PC-type com-
puter with Spike/Spidi software package [40]. The fibers
were characterized as unmyelinated (C) according to their
conduction velocity (c.v.< 1.4 m/s) as calculated from the
latency of the action potential electrically evoked at the
receptive field and the distance between receptive field
and recording electrode. The receptive field was identified
by mechanical probing of the skin with a glass rod; stan-
dard heat stimuli linearly rising the intracutaneous tem-
perature from 31 ± 1°C to 47°C were applied. A fiber was
considered heat sensitive if 3 or more action potentials
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were challenged with OSM (5 ng/ml in synthetic intersti-
tial fluid solution) for 5 minutes and subsequently
recorded during a second heat stimulus. The heat thresh-
old was defined as the temperature that elicited the third
spike of the response.
Behavioral testing
Standard testing procedures were used to quantify signs
of nociceptive behavior. The area tested was the plantar
side of the hindpaw. Heat sensitivity was assessed using
the Hargreaves test [41]. Paw withdrawal latency in
response to an increasing radiant heat stimulus was
measured automatically (Ugo Basile) before and after
OSM (10 ng/ml, PBS) injection.
Statistical analysis
For detailed statistical analysis the Origin 7.0 (Originlab)
and Sigmastat 3.0 (Aspire Software International) were
used. Data are presented as mean ± SEM and were ana-
lyzed using the Wilcoxon signed rank test, Mann Whit-
ney-U test or two-way repeated-measures ANOVA for
comparison between groups and test days. Differences
were considered statistically significant at p < 0.05.
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